Medtech fundings in August 2014

Fundings in medical technology for the month of August 2014 totaled a tepid $199 million, the largest of which are the $55 million funding of Civitas Therapeutics and the $30 million funding of OptiNose. Below were the top fundings for the month.

Company, fundingProduct/technology
Civitas Therapeutics, inc. has raised $55.25 million in a round of funding according to a regulatory filingRespiratory drug delivery
OptiNose, Inc., has raised $30 million of a planned $35 million round of funding according to a regulatory filingPowered intranasal drug delivery
Claret Medical, Inc., has raised up to $18 million in a Series B round of funding according to press reportsCatheter for cerebral protection during transcatheter aortic valve implantation
Silk Road Medical, Inc., has raised $15 million of a planned $22.5 million round of funding according to a regulatory filingTranscarotid stent for treatment of neurovascular disorders
ViaCyte, Inc., has raised $15 million in a round of funding according to a regulatory filingCell therapy-based artificial pancreas for diabetes
Seventh Sense Biosystems, Inc., has raised $10.47 million of a planned $16.47 million round of funding according to a regulatory filingPhlebotomy technologies

For the complete list of medtech fundings in August 2014, see link. For a historical list of the fundings in medtech, by month, since 2009, see link.

Leave a Reply